Less Ads, More Data, More Tools Register for FREE

Pin to quick picksHaydale Plc Regulatory News (HAYD)

Share Price Information for Haydale Plc (HAYD)

Share Price is delayed by 15 minutes
Get Live Data
0.325    -0.0025 (-0.76%)
Bid:
0.32
Ask:
0.33
Spread: 0.01 (3.125%)
Market Cap: £25.27m
HAYD Live PriceLast checked at - London Stock Exchange

Intraday Haydale Plc Share Chart

Director's Dealing

23 May 2014 11:36

HAYDALE GRAPHENE INDUSTRIES PLC - Director's Dealing

HAYDALE GRAPHENE INDUSTRIES PLC - Director's Dealing

PR Newswire

London, May 23

Haydale Graphene Industries plc (the "Company") Director's Dealing On 21 May 2014, Christopher Spacie, Technical Director of the Company purchased5,443 ordinary shares of 2p each at a price of 110.23p per share and followingthis transaction he is now interested in 27,151 ordinary shares of 2p each inthe Company, representing 0.24% of the total voting rights of the Company of11,247,823 shares. For further information please contact: Haydale Graphene Industries plc 01269 842 946John Knowles, ChairmanRay Gibbs, Chief Executive Officer Cairn Financial Advisers LLP (Nomad) 0207 148 7900Tony RawlinsonPaul Trendell Cantor Fitzgerald Europe (Joint Broker)David Foreman 020 7894 7684Paul Jewell 020 7894 7644 Hume Capital Securities plc (Joint Broker) 020 3693 1470Guy PetersDavid Lawman Hermes Financial PRTrevor Phillips 07889 153 628Chris Steele 07979 604 687
Date   Source Headline
22nd Nov 20245:27 pmRNSHolding(s) in Company
21st Nov 202411:48 amRNSDirectorate Change
15th Nov 20242:06 pmRNSHolding(s) in Company
14th Nov 20242:45 pmRNSHolding(s) in Company
13th Nov 20242:10 pmRNSResult of General Meeting and TVR
28th Oct 20245:12 pmRNSResult of Retail Offer
28th Oct 20247:00 amRNSResult of Fundraising
25th Oct 20242:20 pmRNSRetail Offer
25th Oct 20242:15 pmRNSProposed Fundraise to raise up to £3.5 million
9th Jul 20247:00 amRNSNew Agreement Worth US$4.0 million
20th May 20247:00 amRNSTrading Update
2nd May 20247:00 amRNSGrant of Share Options and PDMR Dealing
12th Mar 20247:00 amRNSInterim Results
26th Jan 20247:00 amRNSGrant of Options & Surrender of Existing Options
22nd Jan 20247:00 amRNSHaydale selected for Innovate UK Scaleup Programme
7th Dec 202311:36 amRNSResult of AGM
7th Dec 202311:34 amRNSDirectorate Change
6th Dec 20237:00 amRNSHaydale awarded SMART funding
16th Nov 20232:31 pmRNSHolding(s) in Company
13th Nov 20237:00 amRNSPosting of Annual Report & Notice of AGM
1st Nov 20237:00 amRNSTotal Voting Rights
26th Oct 20237:00 amRNSFinal Results
9th Oct 20238:23 amRNSHolding(s) in Company
5th Oct 20231:43 pmRNSDirector/PDMR Shareholding & Total Voting Rights
4th Oct 20234:46 pmRNSHolding(s) in Company
3rd Oct 20233:48 pmRNSResult of General Meeting
2nd Oct 20237:00 amRNSTotal Voting Rights
22nd Sep 20234:30 pmRNSResult of Retail Offer and Total Voting Rights
15th Sep 20236:12 pmRNSResult of Fundraising
15th Sep 20234:00 pmRNSLaunch of Retail Offer
15th Sep 20233:00 pmRNSProposed Placing, Subscription & Retail Offer
15th Sep 20237:00 amRNSWarrant Expiry, Block Admission Cancellation & TVR
22nd Aug 20237:00 amRNSCollaboration with PETRONAS
4th Aug 20231:02 pmRNSHolding(s) in Company
2nd Aug 20237:00 amRNSDirectorate Change
24th Jul 20237:00 amRNSContract Award
13th Jul 20237:00 amRNSHaydale Delivers LPHW Prototype for Cadent
21st Jun 20237:00 amRNSTrading Update
5th Jun 20237:00 amRNSDirectorate Change
24th May 20237:00 amRNSHaydale to Contribute to the Development of FCHEVs
3rd May 20237:00 amRNSSMART Innovation to Accelerate Graphene Products
26th Apr 20233:06 pmRNSGrant of Share Options
12th Apr 20237:00 amRNSHaydale and Saint-Gobain Collaborate on hBN
16th Mar 20237:00 amRNSHaydale and City Energy Develop UFH with Plumbase
14th Mar 20238:15 amRNSBlock listing Interim Review
10th Mar 202311:05 amRNSSecond Price Monitoring Extn
10th Mar 202311:00 amRNSPrice Monitoring Extension
10th Mar 20237:00 amRNSDirectorate Change
1st Mar 20237:00 amRNSInterim Results
28th Feb 202311:38 amRNSHaydale and GEIC Proud to Partner for a Sixth Year

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.